Snakebite in Bobo-Dioulasso, Burkina Faso: illustration of realities and challenges for care based on a clinical case

Kyelem, Carole Gilberte; Yaméogo, Tènè Marceline; Ouédraogo, SO; Zoungrana, Jérémie; Poda, G. E. A; Rouamba, Mickael; Ouangré, Abdourahmane; Kissou, S. A; Rouamba, A

doi:10.1590/s1678-91992012000400021

Cited by 5 publications

(4 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 5 In Burkina Faso, snakebites are the fifth most common reason for admittance to Burkina Faso basic health facilities. 6 Human-snake contact occurs mainly during field activities in high grass or during forest walks. However, human-snake contact can also occur around or in houses in regions with a high density of snakes, typically farming regions where grain attracts rodents, which, in turn, attract snakes.…”

Section: Introductionmentioning

confidence: 99%

Snakebite frequencies and envenomation case management in primary health centers of the Bobo-Dioulasso health district (Burkina Faso) from 2014 to 2018

Bamogo

Thiam

Nikièma

et al. 2021

Transactions of the Royal Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Background Snakebite envenomation is a significant public health problem in Burkina Faso. Our study describes the epidemiological and therapeutic aspects of snakebite cases at primary health centers in Houet Province, which is located in the western area of Burkina Faso. Methods We conducted a retrospective study of 664 snakebite cases occurring at 10 primary health centers in Houet Province from January 2014 to December 2018. Data were collected from the patient consultation recording database registry system. Results Affected individuals had a male/female ratio of 1.31. The lowest annual incidences (0.02 [95% CI –0.01 to 0.05] and 0.24 [95% CI 0.05 to 0.43]) were observed in the urban primary health centers of Bolomakoté and Sarfalao, respectively. Rural primary health centers in Nasso in 2016 and in Soumousso in 2014 had the highest annual incidence (13.80 [95% CI 7.59 to 20.00] and 3.92 [95% CI 2.99 to 4.86], respectively). Of the 664 registered snakebite victims, none received antivenom immunotherapy treatment. Conclusion Our study shows that snakebite envenomation incidents are common at the 10 primary health centers in Houet Province. Furthermore, despite the lack of antivenom and often inadequate treatment at these primary health centers, they remain the first point of care for snakebite victims.

show abstract

Section: Introductionmentioning

confidence: 99%

Snakebite frequencies and envenomation case management in primary health centers of the Bobo-Dioulasso health district (Burkina Faso) from 2014 to 2018

Bamogo

Thiam

Nikièma

et al. 2021

Transactions of the Royal Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

show abstract

“…In addition to the methodological aspects, including the collection of reliable data (25), the implications for the management of envenomation in tropical countries with low incomes are emphasized (26,27).…”

Section: Dear Editormentioning

confidence: 99%

African Society of Toxinology: a new opportunity for integrating the control of envenomations in Africa

Chippaux¹

2012

J. Venom. Anim. Toxins incl. Trop. Dis

View full text Add to dashboard Cite

“…to quality antivenom serum is frequently limited [4,7]. Most studies conducted in Burkina Faso have focused on the prevalence or incidence of snakebites [6,8,9], while recent research on complications has been case reports from referral hospitals [10][11][12]. Few studies have explored both the complications of snakebite envenomation and the associated factors.…”

Section: Introductionmentioning

confidence: 99%

Factors Associated With Complications of Snakebite Envenomation in Health Facilities in the Cascades Region of Burkina Faso, 2016 to 2021

Kinda,

Sidibe,

Zongo

et al. 2024

Preprint

View full text Add to dashboard Cite

Snakebite envenomation remains a major cause of morbidity and mortality in rural populations. This study aimed to identify factors associated with complications from snakebite envenomation reported in health facilities in the Cascades region of Burkina Faso. This cross-sectional study used routine data of patients admitted for snakebite envenomation in five health facilities between January 1, 2016, and December 31, 2021. Data were collected on sociodemographic, clinical, and therapeutic characteristics of patients showing signs of envenomation. Bivariate and multivariate analyses were conducted to determine factors associated with complications. Among the 846 patients with envenomation, 355 (42%) experienced complications. Local complications at the bite site included wounds (21.5%) and skin necrosis (12.5%). Systemic complications included hemorrhage (30.5%), shock (16.3%), and coma (4.3%), with a mortality rate of 3.2%. Factors significantly associated with complications were rural residence (AOR: 4.80; 95% CI: 2.21-11.4), incision at the bite site (AOR: 4.31; 95% CI: 2.51-7.52), tourniquet application (AOR: 5.52; 95% CI: 1.42-30.8), bleeding (AOR: 14.2; 95% CI: 8.80-23.4), abnormal vital signs (AOR: 14.3; 95% CI: 9.22-22.7), and non-administration of antivenom serum (AOR: 2.92; 95% CI: 1.8-4.8). These findings highlight the importance of antivenom availability and public awareness to reduce complications from snakebite envenomation.

show abstract

Snakebite in Bobo-Dioulasso, Burkina Faso: illustration of realities and challenges for care based on a clinical case

Cited by 5 publications

References 4 publications

Snakebite frequencies and envenomation case management in primary health centers of the Bobo-Dioulasso health district (Burkina Faso) from 2014 to 2018

Snakebite frequencies and envenomation case management in primary health centers of the Bobo-Dioulasso health district (Burkina Faso) from 2014 to 2018

African Society of Toxinology: a new opportunity for integrating the control of envenomations in Africa

Factors Associated With Complications of Snakebite Envenomation in Health Facilities in the Cascades Region of Burkina Faso, 2016 to 2021

Contact Info

Product

Resources

About